Atara Biotherapeutics Inc
NASDAQ:ATRA
Atara Biotherapeutics Inc
NASDAQ:ATRA
Price:
0.5299 USD
-2.91%
Market Closed
Updated:
May 12, 2024
Atara Biotherapeutics Inc
Net Issuance of Debt
|
Atara Biotherapeutics Inc
Net Issuance of Debt Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Net Issuance of Debt Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Issuance of Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Atara Biotherapeutics Inc
NASDAQ:ATRA
|
Net Issuance of Debt
-$947k
|
CAGR 3-Years
-34%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Net Issuance of Debt
-$4.1B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-21%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Net Issuance of Debt
-$270m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
36%
|
CAGR 10-Years
N/A
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Net Issuance of Debt
$2.6B
|
CAGR 3-Years
51%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-10%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Net Issuance of Debt
-$43.1m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
6%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Net Issuance of Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Atara Biotherapeutics Inc's Net Issuance of Debt?
Net Issuance of Debt
-947k
USD
-947k
USD
Based on the financial report for Dec 31, 2023, Atara Biotherapeutics Inc's Net Issuance of Debt amounts to -947k USD.
What is Atara Biotherapeutics Inc's Net Issuance of Debt growth rate?
Net Issuance of Debt CAGR 5Y
-12%
-12%
Over the last year, the Net Issuance of Debt growth was -82%. The average annual Net Issuance of Debt growth rates for Atara Biotherapeutics Inc have been -34% over the past three years , -12% over the past five years .
You don't have any saved screeners yet
